Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancerYanting Lin, Dongquan Jing, Qiuhua Cao et al.|European Journal of Pharmacology|2023Cited by 38